OECD Economic Surveys: Iceland 2008
Hide / Show Abstract

OECD Economic Surveys: Iceland 2008

OECD's periodic survey of the Icelandic economy. This edition examines the major economic challenges faced by Iceland in 2008, in particular a more effective monetary policy, strengthening the fiscal framework, and improving cost-effectiveness in the health care sector.
Click to Access: 
    http://oecd.metastore.ingenta.com/content/1008031e.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/economics/oecd-economic-surveys-iceland-2008_eco_surveys-isl-2008-en
  • READ
 
Chapter
 

Improving cost-effectiveness in the health-care sector You do not have access to this content

English
Click to Access: 
    http://oecd.metastore.ingenta.com/content/1008031ec006.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/economics/oecd-economic-surveys-iceland-2008/improving-cost-effectiveness-in-the-health-care-sector_eco_surveys-isl-2008-6-en
  • READ
Author(s):
OECD

Hide / Show Abstract

Health outcomes and the quality of health care are very good by international comparison, while income-related health inequality appears to be smaller than in most other countries. However, the health-care system is costly and, according to OECD estimates, public expenditure on health and long-term care could reach 15% of GDP by 2050 if no restraining measures are taken. This highlights the importance of raising cost-effectiveness and spending efficiency more generally. To this end, it would seem advisable to remove impediments to private provision and open up the health sector to competition. At the same time, the introduction of cost-sharing should be considered where it does not exist (as in hospitals), although concerns about equity need to be taken into account. This would relieve the burden on public finances, as would the introduction of spending ceilings, cost-efficiency analysis and activity-based funding arrangements. The high cost of pharmaceuticals should be reduced by promoting competition and the use of inexpensive generic drugs.
Also available in French
 
Visit the OECD web site